Sanofi Group To Sell Doliprane To US Fund
Illustration of Doliprane in Paris, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Florian Poitout/ABACAPRESS.COM
- Product Code
- ILEA003435726
- Registered date
- 2024/10/11 00:00:00
- Credit
- Abaca Press / Kyodo News Images
- Media source
- Poitout Florian/ABACA
- Media size
- 8256 × 5504 pixel
- Resolution
- 300 dpi
- Deployment size
- 2.96(MB)*
- Special instruction
*File size when opened in Photoshop, etc.
